Glassman Wealth Services’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-134
Closed -$2.87K 294
2023
Q4
$2.87K Sell
134
-6
-4% -$103 ﹤0.01% 1236
2023
Q3
$2.51K Buy
140
+108
+338% +$2.06K ﹤0.01% 1262
2023
Q2
$651 Hold
32
﹤0.01% 1581
2023
Q1
$696 Hold
32
﹤0.01% 1552
2022
Q4
$992 Hold
32
﹤0.01% 1425
2022
Q3
$1K Hold
32
﹤0.01% 1324
2022
Q2
$1K Hold
32
﹤0.01% 1335
2022
Q1
$1K Hold
32
﹤0.01% 1315
2021
Q4
$1K Hold
32
﹤0.01% 1292
2021
Q3
$1K Hold
32
﹤0.01% 1267
2021
Q2
$1K Hold
32
﹤0.01% 1222
2021
Q1
$1K Hold
32
﹤0.01% 1183
2020
Q4
$1K Hold
32
﹤0.01% 1147
2020
Q3
$0 Buy
+32
New +$577 ﹤0.01% 1311

Other funds holding ANAB

Glassman Wealth Services's ANAB Position: Q1 2024 in Review

Glassman Wealth Services sold out of AnaptysBio (ANAB) in Q1 2024, closing a stake of 134 shares — an estimated $2.87K sold.

Glassman Wealth Services first reported a position in ANAB in Q3 2020 and held it in 14 quarters. The position peaked at $2.87K in Q4 2023. 133 funds tracked by Wall St. Rank hold ANAB as of Q1 2024.

  • Glassman Wealth Services reported no remaining AnaptysBio position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 134 AnaptysBio shares in Q1 2024, an estimated $2.87K.
  • Glassman Wealth Services first reported a position in AnaptysBio in Q3 2020 and held it in 14 quarters.
  • Glassman Wealth Services's AnaptysBio position peaked at $2.87K in Q4 2023.
  • 133 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.